Vaxart’s Oral COVID-19 Vaccine Candidate Induces Potent Systemic and Mucosal Immune Responses in Preclinical Studies

NEXT STORY
Ayala Pharmaceuticals to Present at Upcoming Investor Conferences
PREV STORY
Medical Tourism Market to Grow Steadily on Account of Active Government Promotion and Support: Fortune Business Insights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases

PRESS RELEASE Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies ...

author_avatar
NASDAQ Market News

Vical Reports Fourth Quarter 2017 Financial and Operational Results

SAN DIEGO, March 15, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial ...

author_avatar
NASDAQ Market News

PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions

Expanding global oncology testing for clinical trials WILMINGTON, N.C., June 01, 2018 (GLOBE NEWSWIRE) ...

author_avatar
NASDAQ Market News